In this engaging discussion, Paul Biondi, Managing Partner at Flagship Pioneering, and Uli Stilz, Vice President at Novo Nordisk, delve into innovative co-creation in biotech. Paul outlines Flagship's Pioneering Medicines model, focusing on transforming platform science into groundbreaking therapies. Uli highlights the BioInnovation Hub's role in collaborating on solutions for obesity and diabetes. Together, they explore how building trust and agile partnerships can accelerate R&D, emphasizing a shift towards addressing unmet medical needs.
